Tolga Can
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tolga Can has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Ayse Elif Erson-Bensan
Department of Biological Sciences, M.E.T.U., Ankara, 06800, Türkiye
8 shared publications Yuan-Fang Wang
4 shared publications- Didem Naz Dioken
Middle East Technical University (METU)
3 shared publications - Ezgi Karaca
Izmir Biomedicine and Genome Center, Izmir, Türkiye
3 shared publications - Ibrahim Ozgul
Middle East Technical University (METU)
3 shared publications Ambuj K. Singh
Department of Computer Science
2 shared publications
Latest Publications
- Open Access
- 21 September 2025
- Published by Taylor & Francis in RNA Biology
- Vol. 22 (1) , 1-21
E2-regulated transcriptome complexity revealed by long-read direct RNA sequencing: from isoform discovery to truncated proteins
Oestrogen receptor alpha (ERα)-positive (ER+) breast cancers are driven by the binding of 17β-oestradiol (E2) to ERα, which transcriptionally regulates target genes. Although microarrays and conventional RNA sequencing have identified E2 target genes, pre-designed probes and short read lengths are limited in their ability to accurately capture complex transcript structures. Long-read sequencing offers a solution by spanning entire transcripts, providing a more complete view of the transcriptome. Here, we employed nanopore long-read direct RNA sequencing (DRS) complemented with 3'-end sequencing, in vitro experiments, and deep learning-based protein modelling to explore the landscape of the E2-responsive transcriptome and protein level implications. Our analysis revealed a range of E2-responsive non-coding and coding isoforms, including intronically polyadenylated (IPA) mRNAs. One of these IPA isoforms was detected for TLE1, which assists ERα-chromatin interactions for a subset of E2 targets. The IPA isoform produces a C-terminus truncated protein that lacks the WDR interaction domain but retains dimerization/tetramerization capacity through its intact N-terminal Q-domain. Structural modelling and protein-based assays confirmed the dimerization potential and nuclear localization of the truncated protein. Functional assays showed that the overexpression of truncated TLE1 reduced the E2-induced upregulation of TFF1 and GREB1, E2-responsive genes, thereby disrupting transcriptional regulation. Importantly, a lower IPA isoform ratio is associated with worse survival in ER+ breast cancers, highlighting clinical relevance. Our study revealed new layers of complexity in the E2-regulated transcriptome, providing insights into truncated proteins. These findings contribute to a deeper understanding of gene regulation and may help the development of new therapeutic strategies.
- 21 September 2025
- Published by Taylor & Francis in RNA Biology
- Vol. 22 (1) , 1-21
Open AccessE2-regulated transcriptome complexity revealed by long-read direct RNA sequencing: from isoform discovery to truncated proteins
Oestrogen receptor alpha (ERα)-positive (ER+) breast cancers are driven by the binding of 17β-oestradiol (E2) to ERα, which transcriptionally regulates target genes. Although microarrays and conventional RNA sequencing have identified E2 target genes, pre-designed probes and short read lengths are limited in their ability to accurately capture complex transcript structures. Long-read sequencing offers a solution by spanning entire transcripts, providing a more complete view of the transcriptome. Here, we employed nanopore long-read direct RNA sequencing (DRS) complemented with 3'-end sequencing, in vitro experiments, and deep learning-based protein modelling to explore the landscape of the E2-responsive transcriptome and protein level implications. Our analysis revealed a range of E2-responsive non-coding and coding isoforms, including intronically polyadenylated (IPA) mRNAs. One of these IPA isoforms was detected for TLE1, which assists ERα-chromatin interactions for a subset of E2 targets. The IPA isoform produces a C-terminus truncated protein that lacks the WDR interaction domain but retains dimerization/tetramerization capacity through its intact N-terminal Q-domain. Structural modelling and protein-based assays confirmed the dimerization potential and nuclear localization of the truncated protein. Functional assays showed that the overexpression of truncated TLE1 reduced the E2-induced upregulation of TFF1 and GREB1, E2-responsive genes, thereby disrupting transcriptional regulation. Importantly, a lower IPA isoform ratio is associated with worse survival in ER+ breast cancers, highlighting clinical relevance. Our study revealed new layers of complexity in the E2-regulated transcriptome, providing insights into truncated proteins. These findings contribute to a deeper understanding of gene regulation and may help the development of new therapeutic strategies.
- Open Access
E2-Regulated Transcriptome Complexity Revealed by Long-Read Direct RNA Sequencing: From Isoform Discovery to Truncated Proteins
Estrogen receptor alpha (ERα)-positive (ER+) breast cancers are driven by 17β-estradiol (E2) binding to ERα, which transcriptionally regulates downstream target genes. Although microarrays and conventional RNA sequencing have identified E2 target genes, pre-designed probes and short read lengths are limited in accurately capturing complex transcript structures. Long-read RNA sequencing offers a solution by spanning entire transcripts, providing a more complete view of the transcriptome. Here, we employed nanopore long-read direct RNA sequencing (DRS) complemented with 3’-end sequencing, in vitro experiments, and deep learning-based protein modeling to explore the intricate landscape of E2-responsive transcriptome and protein level implications. Our analysis revealed a range of E2-responsive non-coding and coding isoforms, including intronically polyadenylated (IPA) mRNAs. One of these IPA isoforms was detected for TLE1 (Transducin-like enhancer protein 1), which positively assists ERα-chromatin interactions for a subset of E2 target genes. The IPA isoform produces a C-terminus truncated protein, lacking the WDR interaction domain, but retains dimerization/tetramerization capacity through its intact N-terminus Q-domain. Structural modeling and protein-based assays confirmed the truncated protein’s dimerization potential and nuclear localization. Functional assays showed that overexpression of truncated TLE1 reduces the E2-induced upregulation of GREB1 , an E2-responsive gene, thereby disrupting transcriptional regulation. Importantly, a lower IPA isoform ratio is associated with worse survival in ER+ patients, highlighting clinical relevance. Our study uncovers new layers of complexity in the E2-regulated transcriptome, providing insights into truncated proteins. These findings contribute to a deeper understanding of gene regulation and may help the development of new therapeutic strategies.
Open AccessE2-Regulated Transcriptome Complexity Revealed by Long-Read Direct RNA Sequencing: From Isoform Discovery to Truncated Proteins
Estrogen receptor alpha (ERα)-positive (ER+) breast cancers are driven by 17β-estradiol (E2) binding to ERα, which transcriptionally regulates downstream target genes. Although microarrays and conventional RNA sequencing have identified E2 target genes, pre-designed probes and short read lengths are limited in accurately capturing complex transcript structures. Long-read RNA sequencing offers a solution by spanning entire transcripts, providing a more complete view of the transcriptome. Here, we employed nanopore long-read direct RNA sequencing (DRS) complemented with 3’-end sequencing, in vitro experiments, and deep learning-based protein modeling to explore the intricate landscape of E2-responsive transcriptome and protein level implications. Our analysis revealed a range of E2-responsive non-coding and coding isoforms, including intronically polyadenylated (IPA) mRNAs. One of these IPA isoforms was detected for TLE1 (Transducin-like enhancer protein 1), which positively assists ERα-chromatin interactions for a subset of E2 target genes. The IPA isoform produces a C-terminus truncated protein, lacking the WDR interaction domain, but retains dimerization/tetramerization capacity through its intact N-terminus Q-domain. Structural modeling and protein-based assays confirmed the truncated protein’s dimerization potential and nuclear localization. Functional assays showed that overexpression of truncated TLE1 reduces the E2-induced upregulation of GREB1 , an E2-responsive gene, thereby disrupting transcriptional regulation. Importantly, a lower IPA isoform ratio is associated with worse survival in ER+ patients, highlighting clinical relevance. Our study uncovers new layers of complexity in the E2-regulated transcriptome, providing insights into truncated proteins. These findings contribute to a deeper understanding of gene regulation and may help the development of new therapeutic strategies.
- 19 November 2021
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 90 (3) , 889-897
A C‐term truncated EIF2Bγ protein encoded by an intronically polyadenylated isoform introduces unfavorable EIF2Bγ–EIF2γ interactions
Eukaryotic translation initiates upon recruitment of the EIF2‐GTP·Met‐tRNAi ternary complex (TC) to the ribosomes. EIF2 (α, β, γ subunits) is a GTPase. The GDP to GTP exchange within EIF2 is facilitated by the guanine nucleotide exchange factor EIF2B (α‐ε subunits). During stress‐induced conditions, phosphorylation of the α‐subunit of EIF2 turns EIF2 into an inhibitor of EIF2B. In turn, inhibition of EIF2B decreases TC formation and triggers the internal stress response (ISR), which determines the cell fate. Deregulated ISR has been linked to neurodegenerative disorders and cancer, positioning EIF2B as a promising therapeutic target. Hence, a better understanding of the mechanisms/factors that regulate EIF2B activity is required. Here, combining transcript and protein level analyses, we describe an intronically polyadenylated (IPA) transcript of EIF2B's γ‐subunit. We show that the IPA mRNA isoform is translated into a C‐terminus truncated protein. Using structural modeling, we predict that the truncated EIF2Bγ protein has unfavorable interactions with EIF2γ, leading to a potential decrease in the stability of the nonproductive EIF2:EIF2B complex. While we discovered and confirmed the IPA mRNA isoform in breast cancer cells, the expression of this isoform is not cancer‐specific and is widely present in normal tissues. Overall, our data show that a truncated EIF2Bγ protein co‐exists with the canonical protein and is an additional player to regulate the equilibrium between productive and nonproductive states of the EIF2:EIF2B complex. These results may have implications in stress‐induced translation control in normal and disease states. Our combinatorial approach demonstrates the need to study noncanonical mRNA and protein isoforms to understand protein interactions and intricate molecular mechanisms.
- 19 November 2021
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 90 (3) , 889-897
A C‐term truncated EIF2Bγ protein encoded by an intronically polyadenylated isoform introduces unfavorable EIF2Bγ–EIF2γ interactions
Eukaryotic translation initiates upon recruitment of the EIF2‐GTP·Met‐tRNAi ternary complex (TC) to the ribosomes. EIF2 (α, β, γ subunits) is a GTPase. The GDP to GTP exchange within EIF2 is facilitated by the guanine nucleotide exchange factor EIF2B (α‐ε subunits). During stress‐induced conditions, phosphorylation of the α‐subunit of EIF2 turns EIF2 into an inhibitor of EIF2B. In turn, inhibition of EIF2B decreases TC formation and triggers the internal stress response (ISR), which determines the cell fate. Deregulated ISR has been linked to neurodegenerative disorders and cancer, positioning EIF2B as a promising therapeutic target. Hence, a better understanding of the mechanisms/factors that regulate EIF2B activity is required. Here, combining transcript and protein level analyses, we describe an intronically polyadenylated (IPA) transcript of EIF2B's γ‐subunit. We show that the IPA mRNA isoform is translated into a C‐terminus truncated protein. Using structural modeling, we predict that the truncated EIF2Bγ protein has unfavorable interactions with EIF2γ, leading to a potential decrease in the stability of the nonproductive EIF2:EIF2B complex. While we discovered and confirmed the IPA mRNA isoform in breast cancer cells, the expression of this isoform is not cancer‐specific and is widely present in normal tissues. Overall, our data show that a truncated EIF2Bγ protein co‐exists with the canonical protein and is an additional player to regulate the equilibrium between productive and nonproductive states of the EIF2:EIF2B complex. These results may have implications in stress‐induced translation control in normal and disease states. Our combinatorial approach demonstrates the need to study noncanonical mRNA and protein isoforms to understand protein interactions and intricate molecular mechanisms.
- 17 May 2021
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 37 (22) , 4238-4239
MotifGenie: a Python application for searching transcription factor binding sequences using ChIP-Seq datasets
Motivation: Next generation sequencing enabled the fast accumulation of genomic data at public repositories. This technology also made it possible to better understand the regulation of gene expression by transcription factors (TFs) and various chromatin-associated proteins through the integration of chromatin immunoprecipitation (ChIP-Seq). The Cistrome Project has become one of the indispensable research portals for biologists to access and analyze data generated with thousands of ChIP-Seq experiments. Integrative motif analysis on shared binding regions among a set of experiments is not yet achievable despite a set of search and analysis tools provided by Cistrome via its web interface and the Galaxy framework. Results: We implemented a python command-line tool for searching binding sequences of a TF common to multiple ChIP-Seq experiments. We use the peaks in the Cistrome database as identified by MACS 2.0 for each experiment and identify shared peak regions in a genomic locus of interest. We then scan these regions for binding sequences using a binding motif of a TF obtained from the JASPAR database. MotifGenie is developed in collaboration with molecular biologists and its findings are corroborated by laboratory experiments. Availability and implementation: MotifGenie is freely available at https://github.com/ceragoguztuzun/MotifGenie.
- 17 May 2021
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 37 (22) , 4238-4239
MotifGenie: a Python application for searching transcription factor binding sequences using ChIP-Seq datasets
Motivation: Next generation sequencing enabled the fast accumulation of genomic data at public repositories. This technology also made it possible to better understand the regulation of gene expression by transcription factors (TFs) and various chromatin-associated proteins through the integration of chromatin immunoprecipitation (ChIP-Seq). The Cistrome Project has become one of the indispensable research portals for biologists to access and analyze data generated with thousands of ChIP-Seq experiments. Integrative motif analysis on shared binding regions among a set of experiments is not yet achievable despite a set of search and analysis tools provided by Cistrome via its web interface and the Galaxy framework. Results: We implemented a python command-line tool for searching binding sequences of a TF common to multiple ChIP-Seq experiments. We use the peaks in the Cistrome database as identified by MACS 2.0 for each experiment and identify shared peak regions in a genomic locus of interest. We then scan these regions for binding sequences using a binding motif of a TF obtained from the JASPAR database. MotifGenie is developed in collaboration with molecular biologists and its findings are corroborated by laboratory experiments. Availability and implementation: MotifGenie is freely available at https://github.com/ceragoguztuzun/MotifGenie.
- Open Access
- 8 March 2019
- Published by Springer Nature in BMC Bioinformatics
- Vol. 20 (1) , 1-14
JOA: Joint Overlap Analysis of multiple genomic interval sets
Next-generation sequencing (NGS) technologies have produced large volumes of genomic data. One common operation on heterogeneous genomic data is genomic interval intersection. Most of the existing tools impose restrictions such as not allowing nested intervals or requiring intervals to be sorted when finding overlaps in two or more interval sets. We proposed segment tree (ST) and indexed segment tree forest (ISTF) based solutions for intersection of multiple genomic interval sets in parallel. We developed these methods as a tool, Joint Overlap Analysis (JOA), which takes n interval sets and finds overlapping intervals with no constraints on the given intervals. The proposed indexed segment tree forest is a novel composite data structure, which leverages on indexing and natural binning of a segment tree. We also presented construction and search algorithms for this novel data structure. We compared JOA ST and JOA ISTF with each other, and with other interval intersection tools for verification of its correctness and for showing that it attains comparable execution times. We implemented JOA in Java using the fork/join framework which speeds up parallel processing by taking advantage of all available processor cores. We compared JOA ST with JOA ISTF and showed that segment tree and indexed segment tree forest methods are comparable with each other in terms of execution time and memory usage. We also carried out execution time comparison analysis for JOA and other tools and demonstrated that JOA has comparable execution time and is able to further reduce its running time by using more processors per node. JOA can be run using its GUI or as a command line tool. JOA is available with source code at https://github.com/burcakotlu/JOA/ . A user manual is provided at https://joa.readthedocs.org
- 8 March 2019
- Published by Springer Nature in BMC Bioinformatics
- Vol. 20 (1) , 1-14
Open AccessJOA: Joint Overlap Analysis of multiple genomic interval sets
Next-generation sequencing (NGS) technologies have produced large volumes of genomic data. One common operation on heterogeneous genomic data is genomic interval intersection. Most of the existing tools impose restrictions such as not allowing nested intervals or requiring intervals to be sorted when finding overlaps in two or more interval sets. We proposed segment tree (ST) and indexed segment tree forest (ISTF) based solutions for intersection of multiple genomic interval sets in parallel. We developed these methods as a tool, Joint Overlap Analysis (JOA), which takes n interval sets and finds overlapping intervals with no constraints on the given intervals. The proposed indexed segment tree forest is a novel composite data structure, which leverages on indexing and natural binning of a segment tree. We also presented construction and search algorithms for this novel data structure. We compared JOA ST and JOA ISTF with each other, and with other interval intersection tools for verification of its correctness and for showing that it attains comparable execution times. We implemented JOA in Java using the fork/join framework which speeds up parallel processing by taking advantage of all available processor cores. We compared JOA ST with JOA ISTF and showed that segment tree and indexed segment tree forest methods are comparable with each other in terms of execution time and memory usage. We also carried out execution time comparison analysis for JOA and other tools and demonstrated that JOA has comparable execution time and is able to further reduce its running time by using more processors per node. JOA can be run using its GUI or as a command line tool. JOA is available with source code at https://github.com/burcakotlu/JOA/ . A user manual is provided at https://joa.readthedocs.org
- Open Access
Alternative Polyadenylation Patterns for Novel Gene Discovery and Classification in Cancer
- Open Access
- 19 June 2017
- Published by Springer Nature in BMC Bioinformatics
- Vol. 18 (1) , 306
A multiplex primer design algorithm for target amplification of continuous genomic regions
Targeted Next Generation Sequencing (NGS) assays are cost-efficient and reliable alternatives to Sanger sequencing. For sequencing of very large set of genes, the target enrichment approach is suitable. However, for smaller genomic regions, the target amplification method is more efficient than both the target enrichment method and Sanger sequencing. The major difficulty of the target amplification method is the preparation of amplicons, regarding required time, equipment, and labor. Multiplex PCR (MPCR) is a good solution for the mentioned problems. We propose a novel method to design MPCR primers for a continuous genomic region, following the best practices of clinically reliable PCR design processes. On an experimental setup with 48 different combinations of factors, we have shown that multiple parameters might effect finding the first feasible solution. Increasing the length of the initial primer candidate selection sequence gives better results whereas waiting for a longer time to find the first feasible solution does not have a significant impact. We generated MPCR primer designs for the HBB whole gene, MEFV coding regions, and human exons between 2000 bp to 2100 bp-long. Our benchmarking experiments show that the proposed MPCR approach is able produce reliable NGS assay primers for a given sequence in a reasonable amount of time.
- 19 June 2017
- Published by Springer Nature in BMC Bioinformatics
- Vol. 18 (1) , 306
Open AccessA multiplex primer design algorithm for target amplification of continuous genomic regions
Targeted Next Generation Sequencing (NGS) assays are cost-efficient and reliable alternatives to Sanger sequencing. For sequencing of very large set of genes, the target enrichment approach is suitable. However, for smaller genomic regions, the target amplification method is more efficient than both the target enrichment method and Sanger sequencing. The major difficulty of the target amplification method is the preparation of amplicons, regarding required time, equipment, and labor. Multiplex PCR (MPCR) is a good solution for the mentioned problems. We propose a novel method to design MPCR primers for a continuous genomic region, following the best practices of clinically reliable PCR design processes. On an experimental setup with 48 different combinations of factors, we have shown that multiple parameters might effect finding the first feasible solution. Increasing the length of the initial primer candidate selection sequence gives better results whereas waiting for a longer time to find the first feasible solution does not have a significant impact. We generated MPCR primer designs for the HBB whole gene, MEFV coding regions, and human exons between 2000 bp to 2100 bp-long. Our benchmarking experiments show that the proposed MPCR approach is able produce reliable NGS assay primers for a given sequence in a reasonable amount of time.
- Open Access
- 22 March 2017
- Published by Springer Nature in BMC Bioinformatics
- Vol. 18 (S4) , 41-50
Comparison of tissue/disease specific integrated networks using directed graphlet signatures
Analysis of integrated genome-scale networks is a challenging problem due to heterogeneity of high-throughput data. There are several topological measures, such as graphlet counts, for characterization of biological networks. In this paper, we present methods for counting small sub-graph patterns in integrated genome-scale networks which are modeled as labeled multidigraphs. We have obtained physical, regulatory, and metabolic interactions between H. sapiens proteins from the Pathway Commons database. The integrated network is filtered for tissue/disease specific proteins by using a large-scale human transcriptional profiling study, resulting in several tissue and disease specific sub-networks. We have applied and extended the idea of graphlet counting in undirected protein-protein interaction (PPI) networks to directed multi-labeled networks and represented each network as a vector of graphlet counts. Graphlet counts are assessed for statistical significance by comparison against a set of randomized networks. We present our results on analysis of differential graphlets between different conditions and on the utility of graphlet count vectors for clustering multiple condition specific networks. Our results show that there are numerous statistically significant graphlets in integrated biological networks and the graphlet signature vector can be used as an effective representation of a multi-labeled network for clustering and systems level analysis of tissue/disease specific networks.
- 22 March 2017
- Published by Springer Nature in BMC Bioinformatics
- Vol. 18 (S4) , 41-50
Open AccessComparison of tissue/disease specific integrated networks using directed graphlet signatures
Analysis of integrated genome-scale networks is a challenging problem due to heterogeneity of high-throughput data. There are several topological measures, such as graphlet counts, for characterization of biological networks. In this paper, we present methods for counting small sub-graph patterns in integrated genome-scale networks which are modeled as labeled multidigraphs. We have obtained physical, regulatory, and metabolic interactions between H. sapiens proteins from the Pathway Commons database. The integrated network is filtered for tissue/disease specific proteins by using a large-scale human transcriptional profiling study, resulting in several tissue and disease specific sub-networks. We have applied and extended the idea of graphlet counting in undirected protein-protein interaction (PPI) networks to directed multi-labeled networks and represented each network as a vector of graphlet counts. Graphlet counts are assessed for statistical significance by comparison against a set of randomized networks. We present our results on analysis of differential graphlets between different conditions and on the utility of graphlet count vectors for clustering multiple condition specific networks. Our results show that there are numerous statistically significant graphlets in integrated biological networks and the graphlet signature vector can be used as an effective representation of a multi-labeled network for clustering and systems level analysis of tissue/disease specific networks.
- Open Access
- 2 October 2016
- Published by Association for Computing Machinery (ACM)
- p. 533-534
Comparison of tissue/disease specific integrated networks using directed graphlet signatures
We present a novel framework for counting small sub-graph patterns in integrated genome-scale networks. An integrated network was built using the physical, regulatory, and metabolic interactions between H. sapiens proteins from the Pathway Commons database. The network was filtered for tissue/disease specific proteins by using a large-scale human transcriptional profiling study, resulting in several tissue and disease specific sub-networks. In this study, we apply and extend the idea of graphlet counting in undirected protein-protein interaction (PPI) networks to directed multi-labeled networks and represent each network as a vector of graphlet counts. Graphlet counts are assessed for statistical significance by comparison against a set of randomized networks. We present our results on analysis of differential graphlets between different conditions. Our results show that graphlets can be used for identification of systems level differences between disease states.
- 2 October 2016
- Published by Association for Computing Machinery (ACM)
- p. 533-534
Open AccessComparison of tissue/disease specific integrated networks using directed graphlet signatures
We present a novel framework for counting small sub-graph patterns in integrated genome-scale networks. An integrated network was built using the physical, regulatory, and metabolic interactions between H. sapiens proteins from the Pathway Commons database. The network was filtered for tissue/disease specific proteins by using a large-scale human transcriptional profiling study, resulting in several tissue and disease specific sub-networks. In this study, we apply and extend the idea of graphlet counting in undirected protein-protein interaction (PPI) networks to directed multi-labeled networks and represent each network as a vector of graphlet counts. Graphlet counts are assessed for statistical significance by comparison against a set of randomized networks. We present our results on analysis of differential graphlets between different conditions. Our results show that graphlets can be used for identification of systems level differences between disease states.